%0 Journal Article
%T De novo entecavir+adefovir dipivoxil+lamivudine triple-resistance mutations resulting from sequential therapy with adefovir dipivoxil, and lamivudine
%A Huichun Xing
%A Qi Wang
%A Shunai Liu
%A Song Yang
%A Xiaomei Wang
%J Archive of "Annals of Clinical Microbiology and Antimicrobials".
%D 2016
%R 10.1186/s12941-016-0138-0
%X Entecavir-resistance mutations are commonly induced by entecavir treatment in chronic hepatitis B patients. However, entecavir+adefovir dipivoxil+lamivudine triple-resistance mutations induced by sequential or combination treatment with lamivudine and adefovir dipivoxil have never been reported
%K Hepatitis B virus
%K Multidrug resistance
%K Entecavir
%K Adefovir dipivoxil
%K Lamivudine
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832522/